Brucella abortus S19 GFP-tagged vaccine allows the serological identification of vaccinated cattle.


Journal

PloS one
ISSN: 1932-6203
Titre abrégé: PLoS One
Pays: United States
ID NLM: 101285081

Informations de publication

Date de publication:
2021
Historique:
received: 16 07 2021
accepted: 05 11 2021
entrez: 22 11 2021
pubmed: 23 11 2021
medline: 5 1 2022
Statut: epublish

Résumé

Bovine brucellosis induces abortion in cows, produces important economic losses, and causes a widely distributed zoonosis. Its eradication was achieved in several countries after sustained vaccination with the live attenuated Brucella abortus S19 vaccine, in combination with the slaughtering of serologically positive animals. S19 induces antibodies against the smooth lipopolysaccharide (S-LPS), making difficult the differentiation of infected from vaccinated bovines. We developed an S19 strain constitutively expressing the green fluorescent protein (S19-GFP) coded in chromosome II. The S19-GFP displays similar biological characteristics and immunogenic and protective efficacies in mice to the parental S19 strain. S19-GFP can be distinguished from S19 and B. abortus field strains by fluorescence and multiplex PCR. Twenty-five heifers were vaccinated withS19-GFP (5×109 CFU) by the subcutaneous or conjunctival routes and some boosted with GFP seven weeks thereafter. Immunized animals were followed up for over three years and tested for anti-S-LPS antibodies by both the Rose Bengal test and a competitive ELISA. Anti-GFP antibodies were detected by an indirect ELISA and Western blotting. In most cases, anti-S-LPS antibodies preceded for several weeks those against GFP. The anti-GFP antibody response was higher in the GFP boosted than in the non-boosted animals. In all cases, the anti-GFP antibodies persisted longer, or at least as long, as those against S-LPS. The drawbacks and potential advantages of using the S19-GFP vaccine for identifying vaccinated animals in infected environments are discussed.

Identifiants

pubmed: 34807952
doi: 10.1371/journal.pone.0260288
pii: PONE-D-21-23262
pmc: PMC8608319
doi:

Substances chimiques

Brucella Vaccine 0
Green Fluorescent Proteins 147336-22-9

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

e0260288

Déclaration de conflit d'intérêts

The authors have declared that no competing interests exist.

Références

Vaccine. 2010 Oct 1;28 Suppl 5:F59-63
pubmed: 20362623
J Immunol Methods. 1983 Aug 12;62(1):15-22
pubmed: 6875264
Prev Vet Med. 2018 Mar 1;151:57-72
pubmed: 29496108
Transbound Emerg Dis. 2019 Jan;66(1):505-516
pubmed: 30375177
Methods Mol Biol. 2014;1197:245-60
pubmed: 25172285
J Clin Microbiol. 1979 Jul;10(1):37-41
pubmed: 115896
Aust Vet J. 1981 Dec;57(12):548-50
pubmed: 7340776
JAMA. 1980 Nov 21;244(20):2318-22
pubmed: 7001058
Vet Microbiol. 2002 Dec 20;90(1-4):31-8
pubmed: 12414131
Vet Immunol Immunopathol. 1988 Oct;19(3-4):205-14
pubmed: 3150885
Infect Immun. 1998 Aug;66(8):3862-6
pubmed: 9673273
Vaccine. 2006 Apr 5;24(15):2910-6
pubmed: 16439039
Infect Immun. 1997 Feb;65(2):798-800
pubmed: 9009345
J Med Microbiol. 2018 May;67(5):681-682
pubmed: 29537364
Cell Microbiol. 2002 Oct;4(10):663-76
pubmed: 12366403
Gene. 1992 Feb 15;111(2):229-33
pubmed: 1347277
Vaccine. 2007 Jan 15;25(5):794-805
pubmed: 17070627
Proc Annu Meet U S Anim Health Assoc. 1978;(82):139-41
pubmed: 287087
Front Microbiol. 2018 May 25;9:1092
pubmed: 29887851
PLoS One. 2008 Jul 23;3(7):e2760
pubmed: 18648644
Vet Res. 2004 Jan-Feb;35(1):1-38
pubmed: 15099501
Vaccine. 2009 Mar 10;27(11):1741-9
pubmed: 19186196
Vet Rec. 1969 Sep 6;85(10):269-70
pubmed: 5812057
Vet Microbiol. 1991 Jul;28(2):171-88
pubmed: 1908158
Infect Immun. 2003 Jun;71(6):3261-71
pubmed: 12761107
Vet Microbiol. 2008 Dec 10;132(3-4):302-11
pubmed: 18565697
Ann Rech Vet. 1976;7(1):1-8
pubmed: 825014
Front Microbiol. 2014 May 13;5:213
pubmed: 24860561
Vet Microbiol. 2002 Dec 20;90(1-4):11-8
pubmed: 12414129
Adv Biotechnol Processes. 1990;13:147-68
pubmed: 2185782
Am J Vet Res. 1952 Jul;13(48):351-8
pubmed: 12976633
Vaccine. 2006 Apr 24;24(17):3461-8
pubmed: 16519974
Dev Biol Stand. 1984;56:681-7
pubmed: 6489640
Nat Protoc. 2006;1(1):153-61
pubmed: 17406227
Nat Methods. 2005 Jun;2(6):443-8
pubmed: 15908923
Front Microbiol. 2016 Sep 29;7:1557
pubmed: 27746773
Vet Res. 2012 Apr 13;43:29
pubmed: 22500859
J Clin Microbiol. 1996 Jan;34(1):165-9
pubmed: 8748294
Vaccine. 2011 Jan 10;29(3):577-82
pubmed: 21056079
J Clin Microbiol. 1980 Dec;12(6):753-60
pubmed: 6796600
Clin Diagn Lab Immunol. 2005 Jan;12(1):141-51
pubmed: 15642999

Auteurs

Carlos Chacón-Díaz (C)

Centro de Investigación en Enfermedades Tropicales, Facultad de Microbiología, Universidad de Costa Rica, San Pedro, San José, Costa Rica.

Ana Zabalza-Baranguá (A)

Instituto de Agrobiotecnología, CSIC-Gobierno de Navarra, Mutilva, Navarra, Spain.

Beatriz San Román (B)

Instituto de Agrobiotecnología, CSIC-Gobierno de Navarra, Mutilva, Navarra, Spain.

José-María Blasco (JM)

Unidad de Sanidad Animal, Centro de Investigación y Tecnología Agroalimentaria (CITA), Gobierno de Aragón, Aragón, Zaragoza, Spain.

Maite Iriarte (M)

Departamento de Microbiología y Parasitología, Instituto de Salud Tropical, Universidad de Navarra, Pamplona, Navarra, Spain.

Dariana Salas-Alfaro (D)

Centro de Investigación en Enfermedades Tropicales, Facultad de Microbiología, Universidad de Costa Rica, San Pedro, San José, Costa Rica.

Gabriela Hernández-Mora (G)

Servicio Nacional de Salud Animal, Ministerio de Agricultura y Ganadería, Lagunilla, Heredia, Costa Rica.

Elías Barquero-Calvo (E)

Programa de Investigación en Enfermedades Tropicales (PIET), Escuela de Medicina Veterinaria, Universidad Nacional, Lagunilla, Heredia, Costa Rica.

Caterina Guzmán-Verri (C)

Programa de Investigación en Enfermedades Tropicales (PIET), Escuela de Medicina Veterinaria, Universidad Nacional, Lagunilla, Heredia, Costa Rica.

Esteban Chaves-Olarte (E)

Centro de Investigación en Enfermedades Tropicales, Facultad de Microbiología, Universidad de Costa Rica, San Pedro, San José, Costa Rica.

María-Jesús Grilló (MJ)

Instituto de Agrobiotecnología, CSIC-Gobierno de Navarra, Mutilva, Navarra, Spain.

Edgardo Moreno (E)

Programa de Investigación en Enfermedades Tropicales (PIET), Escuela de Medicina Veterinaria, Universidad Nacional, Lagunilla, Heredia, Costa Rica.

Articles similaires

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male
Humans Meals Time Factors Female Adult

Classifications MeSH